hormone receptor positive breast cancer
Showing 1 - 5 of 5
HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,
Recruiting
- HER2-positive Breast Cancer
- +5 more
- Pertuzumab+TRASTUZUMAB
- ADJUVANT ENDOCRINE THERAPY
-
Stamford, Connecticut
- +21 more
Dec 12, 2022
Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in Japan, United States (Datopotamab
Recruiting
- Hormone Receptor Positive Breast Cancer
- +2 more
- Datopotamab Deruxtecan (Dato-DXd)
-
Los Angeles, California
- +13 more
Jun 21, 2022
Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer Trial in Worldwide (Abemaciclib, Trastuzumab, Fulvestrant)
Active, not recruiting
- Hormone Receptor Positive Breast Cancer
- HER-2 Positive Breast Cancer
- Abemaciclib
- +3 more
-
Bakersfield, California
- +92 more
Feb 4, 2022
Hormone Receptor Positive Breast Cancer Trial in Worldwide (Everolimus, Letrozole, Exemestane)
Completed
- Hormone Receptor Positive Breast Cancer
- Everolimus
- +4 more
-
Birmingham, Alabama
- +51 more
Jan 12, 2022
Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer
Recruiting
- Metastatic Breast Cancer
- +2 more
- Palbociclib
- +2 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center
Jan 17, 2022